MARSHALL WACE, LLP

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1318757 LONDON, X0

Position in DNTH

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,549,867

-$16,144,814 QoQ

Shares Held

128,743

-62.3% QoQ

Ownership

0.230%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#72

of 269 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names. DNTH ranks #61 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	543,897	$270,169,956
2	INCY	Incyte Corp	1,310,154	$148,519,056
3	RPRX	Royalty Pharma plc	2,450,669	$137,409,009
4	SYRE	Spyre Therapeutics, Inc.	991,693	$88,042,503
5	ALNY	Alnylam Pharmaceuticals, Inc.	259,799	$78,207,292
6	TVTX	Travere Therapeutics, Inc.	1,333,207	$75,739,488
7	MANE	Veradermics, Inc	585,560	$71,988,746
8	DFTX	Definium Therapeutics, Inc.	1,298,946	$61,102,419

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,549,867	128,743	-62.3%	Shares	Other	2026-08-13
2026-03-31	$28,694,681	341,929	-66.1%	Shares	Other	2026-05-15
2025-12-31	$41,561,644	1,008,533	+76.0%	Shares	Other	2026-02-13
2025-09-30	$22,545,110	572,938	+964.0%	Shares	Other	2025-11-13
2024-09-30	$1,474,358	53,848	-50.2%	Shares	Other	2024-11-14
2024-06-30	$2,800,190	108,199	-4.2%	Shares	Other	2024-08-14
2024-03-31	$3,387,900	112,930	—	Shares	Other	2024-05-15
2023-03-31 MGTA	—	157,670	+952.6%	Shares	Other	2023-05-15
2021-06-30 MGTA	—	14,979	-79.5%	Shares	Sole	2021-08-13
2020-12-31 MGTA	—	73,013	0.0%	Shares	Sole	2021-02-16
2020-09-30 MGTA	—	73,013	-54.1%	Shares	Sole	2020-11-16
2020-06-30 MGTA	—	159,213	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.